APP Pharmaceuticals Announces Approval And Launch Of Gemcitabine HCI For Injection, USP In 2 Gram Dosage Form
Links shared publicly online about this topic.
- 282total visits
APP Pharmaceuticals Announces Approval And Launch Of Gemcitabine HCI For Injection, USP In 2 Gram Dosage Form
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA)
View full resource at medicalnewstoday.com
Tags: Cancer Medication, Diet and Nutrition, Drug, Pharma, FDA, Gemzar
Most Recently Shared on May 19, 2011 at 12:07 pm By:
APP Pharmaceuticals Announces Approval And Launch Of Gemcitabine HCI For Injection, USP In 2 Gram Dosage Form http://mnt.to/3W67
Also Shared By:
APP Pharmaceuticals - APP Pharmaceuticals Announces Approval and Launch of Gemcitabine HCI for Injection, USP in 2 Gram Dosage Form
apppharma.com — “APP Pharmaceuticals - APP Pharmaceuticals Announces Approval and Launch of Gemcitabine HCI for Injection, USP in 2 Gram Dosage Form” View full resource at apppharma.com
Most Recently Shared on May 19, 2011 at 3:15 pm By:
Paul Cacciatore Patient Advocate
APP Pharma announces approval & launch of gemcitabine HCI 4 injection, USP in 2 gram dosage form. http://dld.bz/aa9XC
Advertisement
MNT Drug Approvals
@mnt_drugapprov
APP Pharmaceuticals Announces Approval And Launch Of Gemcitabine HCI For Injection, USP In 2 Gram Dosage Form http://mnt.to/3W67 #regulatory
1 year ago...